GlassScriptPhysician profile
Sanjay Bhargava
NPI 1891734083
$2,601.71
in general payments reported to CMS, 2019-2025
27 companies · $709 in 2025
The $709 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $225 · 2021: $301 · 2022: $381 · 2023: $292 · 2024: $322 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,139 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,139.32 |
| Education | $183.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $367.10 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $305.25 | 2019-2025 | Camzyos |
| Abiomed | $304.66 | 2022-2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $230.49 | 2025 | Uptravi, Opsumit, Opsynvi |
| Novartis Pharmaceuticals Corporation | $210.55 | 2021-2024 | |
| Inspire Medical Systems, INC. | $188.58 | 2025 | Inspire |
| Abbott Laboratories | $185.14 | 2019-2022 | |
| Medtronic, INC. | $163.78 | 2024 | Corevalve Evolut R |
| Lundbeck LLC | $98.57 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.57 | 2020-2025 | Lifevest |
| Shockwave Medical, INC | $52.43 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $45.96 | 2022-2024 | Turnpike |
| Alnylam Pharmaceuticals INC. | $43.43 | 2025 | Amvuttra, Onpattro |
| Chiesi USA, INC. | $41.01 | 2019-2021 | |
| Amgen INC. | $34.18 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $31.72 | 2022-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $30.71 | 2019-2021 | |
| Amarin Pharma, INC. | $28.59 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $25.49 | 2024 | Arcalyst |
| Ge Healthcare | $24.76 | 2025 | |
| Esperion Therapeutics, INC. | $22.59 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.46 | 2025 | |
| Sanofi-Aventis U.S. LLC | $18.33 | 2021 | |
| Boston Scientific Corporation | $16.97 | 2025 | Lux-Dx Insertable Cardiac Monitor |
| Philips North America LLC | $15.93 | 2024 | (Az7) Lasers |
| W. L. Gore & Associates, INC. | $15.10 | 2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Kiniksa Pharmaceuticals, LTD. | $13.36 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Bhargava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.